Quantitative proteomic analysis identifies AHNAK (neuroblast differentiation-associated protein AHNAK) as a novel candidate biomarker for bladder urothelial carcinoma diagnosis by liquid-based cytology
We start with the patient: weight history, prior attempts, family history, blood pressure, glucose, cholesterol, liver markers, sleep, medications, mental health, alcohol use, menopause or PMOS context when relevant, and what the patient is actually trying to accomplish
Temperature excursions during shipping can compromise peptide stability and potency
90 LarussaT.LeoneI.SuraciE.ImeneoM.LuzzaF
No payment is collected at delivery
Changes in either tissue or plasma binding can change the apparent volume of distribution determined from plasma concentration measurements